Argus downgraded Pfizer (NYSE: PFE) from Buy to Hold on a weaker outlook.The analyst no longer expect PFE to achieve ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE